Undiagnosed Obstructive Sleep Apnea in Primary Care Clinics
- Institution
- OHIO STATE UNIVERSITY, OH
- Principal investigator
- Ulysses J Magalang
- Funding
- $795K
- Duration
- 2024–2029
Moonbase score
Still being scored
Abstract
Obstructive sleep apnea (OSA) is a major public health problem that is commonly seen in primary care clinics where a majority of outpatient office visits occur. Prior studies suggest that OSA is severely under-diagnosed in primary care practices, but these studies relied on patient reported symptoms rather than objective diagnosis. Consequently, the prevalence of OSA and rate of under-diagnosis of OSA among primary care practices are not currently known. Given the recent studies implicating the excessively sleepy OSA symptom subtype to the development of cardiovascular events, it is also important to ascertain the prevalence and underdiagnosis rate of this OSA subtype among patients seen at primary care clinics. In addition to estimating prevalence, it is equally important to evaluate the factors contributing to the likelihood of underdiagnosis across different primary care practices. Barriers to OSA diagnosis include patient factors related to lack of awareness and understanding of the disease, physician perceptions of OSA risk and knowledge about the heterogeneous presentation of OSA, and system and practice-specific factors such as time constraints. The growth of electronic health records (EHRs) in recent years also provides the unique ability to identify these undiagnosed and untreated cases via the application of automated algorithms. Our preliminary data suggest that combining readily available data in EHRs including comorbidities using machine learning techniques offers an opportunity to develop a reliable OSA phenotypic risk score that would facilitate OSA case identification in primary care. New paradigms for identification of OSA and its subtypes centered on primary care and using data from the EHR, including comorbidities and patient symptoms, are needed to meet the high prevalence of OSA. In Aim 1, using a two-stage sampling strategy in primary care practices, we will determine the prevalence of OSA and its subtypes, and robustly estimate the rate of OSA under-diagnosis in primary care clinics. In Aim 2, we intend to develop a root cause analysis of the underdiagnosis of OSA problem in primary care practice setting using a systems engineering framework. We will elicit the barriers and facilitators of the OSA diagnostic process within the work system of the primary care practice setting using stakeholder engagement methods with multi-level stakeholders. Using these results, we will survey primary care providers and staff to estimate the frequency and priority rank-order of OSA diagnostic process barriers and facilitators within the primary care work system. In Aim 3, using a novel machine learning pipeline, we will develop an efficient and accurate tool for determining OSA risk in primary care participants recruited in Aim 1 and an efficient tool to determine OSA subtype that could be employed within the context of primary care practice. This proposal will ultimately lead to increased identification of OSA and its subtypes in primary care clinics and prioritize treatment of patients that will most benefit from therapy which may reduce the burden of significant health problems that are associated with this very common condition.
Research team
- Ulysses J MagalangPI
- Allan I PackPI
LOADING MOONBASE SCORE
Questions for OHIO STATE UNIVERSITY
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of PennsylvaniaNot yet scored
MicroRNAs as Biomarkers for Obstructive Sleep Apnea
Ulysses J Magalang · $455K · 2023–2028
- NIH · Ohio State University46
Maladaptive Remodeling of the Neuromuscular Synapse Following Central Nervous System Injury
Maria Helen Harley Balch · $41K · 2023–2025
- NIH · Ohio State University46
New approach to sustained neuroprotection and enhanced recovery following acute ischemic stroke
Paco S Herson · $565K · 2022–2027